Endothelin-1 and Endothelin Receptor Gene Variants and Their Association With Negative Outcomes Following Aneurysmal Subarachnoid Hemorrhage

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease that affects approximately 30,000 people a year in the United States. Delayed cerebral ischemia (DCI) and cerebral vasospasm (CV) are common complications after aSAH. In addition, aSAH patients have a high risk of poor long-term outcomes. Endothelin-1 (ET-1), a potent vasoconstrictor, or its two types of receptors, ET receptor A (ETA ) and ET receptor B (ETB), may play a role in the pathogenesis of DCI and CV. Genetic variations within the ET-1, ETA, or ETB genes may also account for variance observed in the outcomes of aSAH patients. The purpose of this study was to describe the distribution of the Lys198Asn polymorphism, a known functional SNP in the ET-1 gene, and tagging SNPs of the ET-1, ETA, and ETB genes in individuals recovering from aSAH. This study also investigated the relationships among the ET polymorphisms, DCI, and global functional outcomes measured at 3 and 6 months after aSAH. Participants included individuals aged 18–75 years with a diagnosis of aSAH. There was a trend found between the variant allele of an ET-1 SNP (rs6912834) and angiographic vasospasm. There were also associations found between two ETB SNPs (rs9574124 and rs3027111) and poor outcomes as measured by the Glasgow Outcome scale at 3 months. These findings support the role of ET-1 and ETB in recovery following aSAH.

[1]  P. Sherwood,et al.  Cerebrospinal Fluid 20-HETE Is Associated With Delayed Cerebral Ischemia and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage , 2011, Stroke.

[2]  A. Kassam,et al.  Role of Endothelin-1 in Human Aneurysmal Subarachnoid Hemorrhage: Associations with Vasospasm and Delayed Cerebral Ischemia , 2011, Neurocritical care.

[3]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[4]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[5]  A. Cruickshank,et al.  Subarachnoid haemorrhage , 2007, The Lancet.

[6]  D. A. Tregouet,et al.  A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies , 2007, Bioinform..

[7]  Y. Goto,et al.  [Deteriorating factors on the outcome in patients with fair grade of subarachnoid hemorrhage (WFNS grade I and II)]. , 2006, No shinkei geka. Neurological surgery.

[8]  J. Sugawara,et al.  Polymorphism in Endothelin-Related Genes Limits Exercise-Induced Decreases in Arterial Stiffness in Older Subjects , 2006, Hypertension.

[9]  H. Markus,et al.  Polymorphisms in Genes of the Endothelin System and Cerebral Small-Vessel Disease , 2005, Stroke.

[10]  S. Lozzi,et al.  Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. , 2005, Surgical neurology.

[11]  B. Stegmayr,et al.  Declining Mortality From Subarachnoid Hemorrhage: Changes in Incidence and Case Fatality From 1985 Through 2000 , 2004, Stroke.

[12]  U. Dirnagl,et al.  Ischemia triggered by spreading neuronal activation is induced by endothelin‐1 and hemoglobin in the subarachnoid space , 2003, Annals of neurology.

[13]  B. Morris,et al.  Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension , 2003, Clinical genetics.

[14]  N. Dorsch.  Therapeutic approaches to vasospasm in subarachnoid hemorrhage , 2002, Current opinion in critical care.

[15]  B. Lévy,et al.  Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro , 2002, Hypertension.

[16]  L. Beilin,et al.  Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy , 2001, Journal of hypertension.

[17]  R. Dietz,et al.  A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. , 2001, European heart journal.

[18]  R J Tamargo,et al.  Cocaine Use Is an Independent Risk Factor for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage , 2001, Stroke.

[19]  T. Asser,et al.  Cerebral hemodynamic impairment after aneurysmal subarachnoid hemorrhage as evaluated using transcranial doppler ultrasonography: relationship to delayed cerebral ischemia and clinical outcome. , 2001, Journal of neurosurgery.

[20]  R. Tamargo,et al.  Risk Factors for Subarachnoid Hemorrhage , 2001, Neurosurgery.

[21]  D. Stewart,et al.  Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage , 2001, Stroke.

[22]  P. Suter,et al.  Review of Medical Prevention of Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Problem of Neurointensive Care , 2001, Neurosurgery.

[23]  G. Hankey,et al.  Epidemiology of Aneurysmal Subarachnoid Hemorrhage in Australia and New Zealand - Incidence and Case Fatality From the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) , 2000 .

[24]  N. Knuckey,et al.  Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). , 2000, Stroke.

[25]  J. De Keyser,et al.  Use of the Barthel index and modified Rankin scale in acute stroke trials. , 1999, Stroke.

[26]  D. Arveiler,et al.  Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Témoins sur l'Infarctus du Myocarde (ECTIM) Study. , 1999, American journal of hypertension.

[27]  G. Teasdale,et al.  Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. , 1998, Journal of neurotrauma.

[28]  G. Kongable,et al.  Using The NIH Stroke Scale to Assess Stroke Patients , 1997, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[29]  K. Uemura,et al.  Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries , 1997, Brain Research.

[30]  C. Sobey,et al.  Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo. , 1996, The American journal of physiology.

[31]  R. Cohen,et al.  Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. , 1995, Circulation.

[32]  S. Tokudome,et al.  Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. , 1995, Journal of neurosurgery.

[33]  M. Nakane,et al.  Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. , 1995, Journal of neurosurgery.

[34]  M. Brown,et al.  Genetic Variability of the ET‐1 and the ETA Receptor Genes in Essential Hypertension , 1995, Journal of Cardiovascular Pharmacology.

[35]  V. Seifert,et al.  Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. , 1995, Journal of neurosurgery.

[36]  I. Wakabayashi,et al.  Impairment of Endothelium‐Dependent Relaxation in Human Basilar Artery After Subarachnoid Hemorrhage , 1992, Stroke.

[37]  T. Sundt,et al.  Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. , 1992, Circulation research.

[38]  F. Takaku,et al.  Endothelin family in human plasma and cerebrospinal fluid. , 1990, The Journal of clinical endocrinology and metabolism.

[39]  S. Sato,et al.  Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage , 1990, Acta neurologica Scandinavica.

[40]  S. Sato,et al.  Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. , 1990, Annals of medicine.

[41]  N. Kassell,et al.  Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage , 1989, Neurology.

[42]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[43]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[44]  H. Schouten,et al.  Agreement between physicians on assessment of outcome following severe head injury. , 1983, Journal of neurosurgery.

[45]  T A Gennarelli,et al.  Influence of the type of intracranial lesion on outcome from severe head injury. , 1982, Journal of neurosurgery.

[46]  B. Jennett.  OUTCOME AFTER SEVERE HEAD INJURY DEFINITIONS AND PREDICTIONS , 1976, The Medical journal of Australia.

[47]  B. Jennett,et al.  ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale , 1975, The Lancet.

[48]  B Jennett,et al.  Assessment of outcome after severe brain damage. , 1975, Lancet.